Cargando…
Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
Autores principales: | Xu, Keman, Khan, Mohsin, Yu, Jun, Snyder, Nathaniel W., Wu, Sheng, Vazquez-Padron, Roberto I., Wang, Hong, Yang, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361401/ https://www.ncbi.nlm.nih.gov/pubmed/35958425 http://dx.doi.org/10.3389/fcvm.2022.981544 |
Ejemplares similares
-
Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023) -
Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022) -
Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022
por: Xu, Keman, et al.
Publicado: (2023) -
Editorial: Insights in cardiovascular imaging: 2021
por: Parasa, Ramya, et al.
Publicado: (2023) -
Editorial: Insights in General Cardiovascular Medicine: 2021
por: Wang, Lijun, et al.
Publicado: (2022)